Olivier Taelman
Chief Executive Officer bei NYXOAH SA
Vermögen: 6 Mio $ am 31.03.2024
Profil
Olivier Taelman is currently the Chief Executive Officer & Executive Director at Nyxoah SA. Prior to his current position, he worked as the Business Director-Neuromodulation at Nevro Corp.
from 2013 to 2015, and as the Vice President-Europe at Autonomic Technologies, Inc. from 2015 to 2019.
Mr. Taelman completed his undergraduate degree at Hasselt University and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NYXOAH SA
1,47% | 18.03.2024 | 419 930 ( 1,47% ) | 6 Mio $ | 31.03.2024 |
Aktive Positionen von Olivier Taelman
| Unternehmen | Position | Beginn |
|---|---|---|
| NYXOAH SA | Chief Executive Officer | 01.11.2019 |
Ehemalige bekannte Positionen von Olivier Taelman
| Unternehmen | Position | Ende |
|---|---|---|
Autonomic Technologies, Inc.
 Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01.11.2019 |
| NEVRO CORP. | Corporate Officer/Principal | 01.12.2015 |
Ausbildung von Olivier Taelman
| Hasselt University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NEVRO CORP. | Health Technology |
| NYXOAH SA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Technology |
